NordiQC references

Vyberg M. et al. Proficiency testing in immunohistochemistry--experiences from Nordic Immunohistochemical Quality Control (NordiQC). - Virchows Arch. 2016;1:19-29
Cheung CC. et al. Uneven Staining in Automated Immunohistochemistry: Cold and Hot Zones and Implications for Immunohistochemical Analysis of Biopsy Specimens. - Appl. Immunohistochem. Mol. Morphol. ;5:299-304
Vyberg M. et al. Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests. - BMC Health Serv Res 2015;:352
Cheung CC. et al. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers. - Appl. Immunohistochem. Mol. Morphol. 2017;1:4-11
Torlakovic EE. et al. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics. - Appl. Immunohistochem. Mol. Morphol. 2017;2:79-85
Torlakovic EE. et al. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories. - Appl. Immunohistochem. Mol. Morphol. 2017;3:151-159
Cheung CC. et al. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry. - Appl. Immunohistochem. Mol. Morphol. 2017;4:227-230
Torlakovic EE. et al. Getting controls under control: the time is now for immunohistochemistry. - J. Clin. Pathol. 2015;11:879-82
Torlakovic EE. et al. Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee. - Appl. Immunohistochem. Mol. Morphol. 2015;1:1-18
Torlakovic EE. et al. Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel. - Appl. Immunohistochem. Mol. Morphol. 2014;4:241-52
Canadian Association of Pathologists-Association canadienne des pathologistes National Standards Committee/Immunohistochemistry: best practice recommendations for standardization of immunohistochemistry tests. - Am. J. Clin. Pathol. 2010;3:354-65
Yaziji H. et al. Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. - Appl. Immunohistochem. Mol. Morphol. 2008;6:513-20
Lykkegaard Andersen N. et al. Virtual Double Staining: A Digital Approach to Immunohistochemical Quantification of Estrogen Receptor Protein in Breast Carcinoma Specimens. - Appl. Immunohistochem. Mol. Morphol. 2018;9:620-626
Vyberg M. et al. NordiQC Assessments of MSH6 Immunoassays. - Appl. Immunohistochem. Mol. Morphol. 2018;7:431-434
Røge R. et al. NordiQC Assessments of PAX8 Immunoassays. - Appl. Immunohistochem. Mol. Morphol. 2018;4:221-224
Vyberg M. et al. NordiQC Assessments of Low Molecular Weight Keratin 8/18 Immunoassays. - Appl. Immunohistochem. Mol. Morphol. ;10:673-678
Røge R. et al. Accurate PD-L1 Protocols for Non-Small Cell Lung Cancer can be Developed for Automated Staining Platforms With Clone 22C3. - Appl. Immunohistochem. Mol. Morphol. 2017;6:381-385
Nielsen SL. et al. Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas. - Appl. Immunohistochem. Mol. Morphol. ;5:320-328
Røge R. et al. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining. - Breast Cancer Res. Treat. 2016;1:11-19
Røge R. et al. Carb-3 is the superior anti-CD15 monoclonal antibody for immunohistochemistry. - Appl. Immunohistochem. Mol. Morphol. 2014;6:449-58
Borrisholt M. et al. Demonstration of CDX2 is highly antibody dependant. - Appl. Immunohistochem. Mol. Morphol. 2013;1:64-72
Røge R. et al. NordiQC Assessments of CD117 Immunoassays. - Appl. Immunohistochem. Mol. Morphol. 2018;: